课题基金 / 基金详情

Establishment of murine strains separately with various autoimmune diseases

Establishment of murine strains separately with various autoimmune diseases
不同自身免疫性疾病小鼠品系的建立
批准号:
05558102
负责人:
NOSE Masato
金额:
$7.55万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995

项目摘要

项目成果

NOSE Masato的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. MRL/lpr, but not C3H/lpr mice, develop autoimmune diseases coincidentally involving vasculitis, arthritis and glomerulonephritis (GN). Two novel congenic strains of mice, which separately developed severe vasculitis and arthritis, respectively, were established from the MRL/lpr and C3H/lpr strains, indicating that these diseases are under the control of suppressor and enhancer genes. 2. By using MRL/lpr x (MRL/lpr x C3H / lpr) F1 mice, we analyzed the linkage of vasculitis with microsatellite makers to find out the corresponding background gene locus. 3. We obtained nephritogenic antibody-producing B cell clones from MRL/lpr mice and were succeeded in cloning of their germline VH genes. These genes were localized also in normal strains of mice. The background genes for GN,thus, are not immunoglobulin genes by themselves and these contribute to the inducing mechanisms of nephritogenic antibodies. 4. Eta-1/Op induces macrophage-and polyclonal B cell-activation. We obseved allelic difference in the Eta-1 gene transcript between MRL and C3H strains, which was enough to induce a functional difference. This can be one of disease-sensitive genes for autoimmune diseases. 5. We newly astablished an MRL strain of mice bearing Fas ligand mutant gene, gld, which developed autoimmune diseases as well as MRL/ipr mice. The treatment with anti-Fas antibodies suppressed and ameliorated the diseases, indicating that the diseases are due to the deficit in Fas/FasL interaction. 6. Transfer of the interferon regulatory factor-1 gene, IRF-1, to MRL/lpr mice induced the selective suppression of autoimmune diseases in MRL/lpr mice. This indicates that some autoimmune diseases, but not all, are under the control of the background genes regulatable by IRF-1.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nose, M.: "Vascular lesions in mice with a deficit in Fas-mediated apoptosis and their transfer" Int, J. Cardiol.,. (in press).
Nose, M.:“Fas 介导的细胞凋亡缺陷小鼠的血管病变及其转移”Int, J. Cardiol.,。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Heyman,B.,et al.: "Antibody feedback regulation in MRL/lpr mice." J.Autoimmunity. 6. 437-448 (1993)
Heyman,B.,et al.:“MRL/lpr 小鼠中的抗体反馈调节。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kanno,H.: "Immune complex-degradation ability of macrophages in MRL/Mp-lpr/lpr lupus mice and its regulation by cytokines" Clin.Exp.Immunol.95. 115-121 (1994)
Kanno,H.:“MRL/Mp-lpr/lpr 狼疮小鼠巨噬细胞的免疫复合物降解能力及其细胞因子的调节”Clin.Exp.Immunol.95。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Resistance genes to collagen disease in a wild mice-derived inbred strain MSM/Ms
    • 批准号:
      20390112
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.31万
    • 财政年份:
      2008
    • 负责人:
      NOSE Masato
    • 依托单位:
    Establishment of a novel recombinant inbred strain of mice MXH/lpr with genetic dissociation of the complex pathological and pathophysiological phenotypes of collagen disease under a polygene network
    • 批准号:
      18390123
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.17万
    • 财政年份:
      2006
    • 负责人:
      NOSE Masato
    • 依托单位:
    A novel mutant gene inhibiting the progression of autoimmune glomerulonephritis
    • 批准号:
      14370077
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.68万
    • 财政年份:
      2002
    • 负责人:
      NOSE Masato
    • 依托单位:
    Pathogenomics of collagen disease using synthetic polymorphic proteins and BAG transgenic mice
    • 批准号:
      13557018
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.58万
    • 财政年份:
      2001
    • 负责人:
      NOSE Masato
    • 依托单位:
    海外基金